Deliver Your News to the World

Evidence Growing On Health Risks From TCE; Current Data Are Sufficient For EPA To Finalize Risk Assessment


July 27, 2006 -- WASHINGTON -- A new report from the National Academies’ National Research Council recommends research to improve understanding of how the environmental contaminant trichloroethylene causes cancer and other adverse health effects, but adds that enough information exists for the U.S. Environmental Protection Agency to complete a credible human health risk assessment now.

In 2001 EPA issued a draft risk assessment on trichloroethylene, a solvent widely used as a degreasing agent that is contaminating air, soil, and water at several military installations and hundreds of waste sites around the country. The release of the draft risk assessment was followed by much debate about the quality of evidence on trichloroethylene and how that evidence should be assessed. This prompted an interagency group to request that a Research Council committee review issues related to assessing the health risks from exposure to trichloroethylene, commonly referred to as TCE. The committee was not asked to conduct a risk assessment of its own.

The evidence on cancer and other health risks from TCE exposure has strengthened since 2001, the committee found. It pointed out that research, including studies of human populations, supports the conclusion that TCE is a potential cause of kidney cancer. Research shows that the chemical may cause other kidney problems as well, but the level of exposure needed to produce kidney damage is not clear. Animal data indicate that relatively high doses of TCE are needed to induce liver toxicity and cancer. Some epidemiology studies indicate a higher incidence of liver cancer among populations exposed to TCE, but the evidence is inconsistent. Studies of people exposed to TCE at work do not show a strong association between exposure and lung tumors, the report notes.

Animal research and human population studies suggest that TCE exposure may also be associated with other health effects, such as reproductive and developmental problems, impaired neurological function, and autoimmune disease. The committee recommended studies to advance understanding of the mechanisms by which TCE causes cancer and other health problems; which populations are most sensitive to TCE’s effects; and how exposure to a mixture of TCE and other chemicals affects human health.

A large body of epidemiological data on TCE and cancer is available, but a new analysis of that data is needed to better characterize the hazard that TCE presents to humans, the committee said. It found several weaknesses in the analysis that EPA used in its draft risk assessment, as well as in an analysis developed by researchers since the draft was issued. To overcome these weaknesses, the new analysis should establish clear criteria for including epidemiological studies based on objective characteristics, the committee said. It added that it would be appropriate for EPA to use a model jointly developed with the U.S. Air Force to simulate how the body metabolizes TCE, although the model does not resolve uncertainty about the mechanisms by which the chemical causes cancer.

A model is being used to extrapolate from animal studies an estimate of the cancer risk posed by TCE at low doses. The risk is extrapolated below a “point of departure,” which is associated with an incremental effect, such as 5 percent more cancers. EPA should consider a range of points of departure in its risk assessment, the committee recommended. Because there is not enough evidence on how TCE triggers cancer to choose the best model for relating the body’s response to different dose levels -- a so-called dose-response model -- it is appropriate under EPA’s cancer guidelines to extrapolate the risk using a linear model, in which cancer risk rises in proportion to dose.

The committee’s report was funded by the U.S. Environmental Protection Agency, U.S. Department of Defense, U.S. Department of Energy, and NASA. The National Research Council is the principal operating arm of the National Academy of Sciences and the National Academy of Engineering. It is a private, nonprofit institution that provides science and technology advice under a congressional charter. A committee roster follows.

Copies of ASSESSING THE HUMAN HEALTH RISKS OF TRICHLOROETHYLENE: KEY SCIENTIFIC ISSUES will be available from the National Academies Press; tel. 202-334-3313 or 1-800-624-6242 or on the Internet at HTTP://WWW.NAP.EDU. Reporters may obtain a pre-publication copy from the Office of News and Public Information.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.